Especially for drug-resistant cancer cells, multiple experimental cancer models have demonstrated that they can be effectively killed by ferroptosis inducers, such as some small molecules and clinical drugs that target FSP1 and GPX4, deprive GSH or improve the iron pool. Here, GPX4 is linked to cancer.